Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access to medicines for patients globally.
Becoming an independent listed company in October 2023 was a pivotal moment for Sandoz that started us on an exciting multi-year journey of transformation and growth. Together, we are shaping the future of Sandoz. Our momentum is driven by our talented and ambitious colleagues, who, in return for applying their skills, experience a supportive and collaborative culture, with impactful, flexible ...
Driving access to make a difference for patients At Sandoz, our Purpose is pioneering access for patients. Our Vision is to be the world’s leading and most valued affordable medicines company. In 2025, we reached over 1 billion patients. We are the only company operating globally at scale in both biosimilars and generics. Our generic medicines range from standard generics – primarily oral ...
Discover how Sandoz is transforming healthcare with high-quality, affordable medicines and biosimilars for people around the world.
About Us Sandoz is the leading global provider of off-patent medicines. These generic and biosimilar medicines are more affordable than reference medicines. With a comprehensive portfolio of around 1,500 products covering most major therapeutic areas and available in over 100 countries, we make a real difference for patients and healthcare systems worldwide.
The Sandoz brand is a seal of quality, and healthcare professionals around the world trust it as a symbol of high-quality, affordable medications.
Sandoz is committed to an effective corporate governance framework that supports its sustainable development and ensures long-term value creation.